# Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease

> **NCT00296959** · PHASE2 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 20 (estimated)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** topiramate (drug)

## Key facts

- **NCT ID:** NCT00296959
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2007-03
- **Target enrollment:** 20 (ESTIMATED)
- **Why stopped:** early termination due to slow recruitment
- **Last updated:** 2007-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00296959

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00296959, "Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00296959. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*